IS
ISRG.US Intuitive Surgical Inc
- Market cap
- USD 154B
- P/E
- 53.6x
- P/B
- 9.62x
- ROE
- 18.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ISRG.US undervalued?
Graham numberThe Graham number of Intuitive Surgical Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Intuitive Surgical Inc fundamental analysis
No fundamental analysis for Intuitive Surgical Inc yet.
Intuitive Surgical Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasi…
Full company profileIntuitive Surgical Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Intuitive Surgical Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.70B | 3.13B | 3.72B | 4.48B | 4.36B | 5.71B | 6.22B | 7.12B | 8.35B | 10.1B | 11.6B |
| Gross Profit | 1.89B | 2.19B | 2.60B | 3.11B | 2.86B | 3.96B | 4.20B | 4.73B | 5.63B | 6.64B | 7.83B |
| Operating Income | 945M | 1.05B | 1.20B | 1.37B | 1.05B | 1.82B | 1.58B | 1.77B | 2.35B | 2.95B | 3.23B |
| EBITDA | 1.04B | 1.15B | 1.32B | 1.58B | 1.33B | 2.13B | 1.97B | 2.41B | 3.14B | 3.99B | 4.02B |
| Net Income | 736M | 660M | 1.13B | 1.38B | 1.06B | 1.70B | 1.32B | 1.80B | 2.32B | 2.86B | 2.88B |
| EPS | 2.08 | 1.89 | 3.16 | 3.85 | 2.94 | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 | 8.20 |
| Balance Sheet | |||||||||||
| Total Assets | 6.49B | 5.76B | 7.85B | 9.73B | 11.2B | 13.6B | 13.0B | 15.4B | 18.7B | 20.5B | 19.3B |
| Total Liabilities | 709M | 1.03B | 1.16B | 1.45B | 1.41B | 1.60B | 1.86B | 2.04B | 2.21B | 2.52B | 3.23B |
| Shareholders' Equity | 5.78B | 4.73B | 6.68B | 8.28B | 9.76B | 12.0B | 11.0B | 13.3B | 16.4B | 17.8B | 16.0B |
| Cash & Short-term Investments | 4.84B | 3.85B | 3.06B | 5.85B | 5.17B | 4.23B | 4.12B | 5.22B | 4.01B | 5.93B | 4.04B |
| Total Debt | - | - | - | 76.4M | 79.9M | 87.0M | 93.8M | 89.8M | 146M | 303M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.04B | 1.14B | 1.17B | 1.60B | 1.48B | 2.09B | 1.49B | 1.81B | 2.42B | 3.03B | 4.26B |
| Capital Expenditure | 53.9M | 191M | 187M | 426M | 342M | 354M | 532M | 1.06B | 1.11B | 540M | 439M |
| Free Cash Flow | 989M | 953M | 982M | 1.17B | 1.14B | 1.74B | 958M | 750M | 1.30B | 2.49B | 3.82B |
| Ratios | |||||||||||
| ROE | 12.7% | 14.0% | 16.9% | 16.6% | 10.9% | 14.3% | 12.0% | 13.5% | 14.1% | 16.0% | 18.0% |
| ROA | 11.3% | 11.5% | 14.4% | 14.2% | 9.5% | 12.6% | 10.2% | 11.6% | 12.4% | 14.0% | 14.9% |
| Net Profit Margin | 27.2% | 21.1% | 30.3% | 30.8% | 24.3% | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% | 24.8% |
| Debt to Equity | - | - | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Intuitive Surgical Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | USD 8.00M | 0.02 | 0.3% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:1 on Oct 5, 2021.
Who owns Intuitive Surgical Inc
- Insiders 0.78%
- Institutions 90.28%
- Public & others 8.94%
- Shares outstanding 347M
- Free float 345M
Top funds holding ISRG.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 11.2M | 3.24% | -0.36% | Sep 2026 |
| Vanguard 500 Index Investor | 9.28M | 2.68% | -1.36% | Sep 2026 |
| Invesco QQQ Trust | 7.35M | 2.12% | -0.10% | Oct 2026 |
| iShares Core S&P 500 ETF | 4.71M | 1.36% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 4.59M | 1.32% | -0.13% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 4.31M | 1.24% | -0.25% | Oct 2026 |
| American Funds Growth Fd of Amer A | 4.02M | 1.16% | +31.68% | Sep 2026 |
| Vanguard MStar Growth Index Investor | 3.92M | 1.13% | +2.70% | Sep 2026 |
| Vanguard Health Care Inv | 2.73M | 0.79% | +17.54% | Sep 2026 |
| State Street®HlthCrSelSectSPDR®ETF | 2.58M | 0.75% | +0.88% | Oct 2026 |
| American Funds New Perspective A | 2.31M | 0.67% | 0.00% | Sep 2026 |
| Vanguard Institutional Index I | 1.87M | 0.54% | -1.29% | Sep 2026 |
| Invesco NASDAQ 100 ETF | 1.68M | 0.48% | +0.15% | Oct 2026 |
| American Funds IS® Growth 1 | 1.46M | 0.42% | -10.80% | Sep 2026 |
| T. Rowe Price Blue Chip Growth | 1.37M | 0.40% | -2.86% | Sep 2026 |
| iShares Russell 1000 Growth ETF | 1.33M | 0.38% | +0.09% | Oct 2026 |
| iShares US Medical Devices ETF | 1.25M | 0.36% | -1.12% | Oct 2026 |
| Vanguard Health Care ETF | 1.08M | 0.31% | +0.13% | Sep 2026 |
| State Street® SPDR® Port S&P 500® ETF | 983K | 0.28% | -0.01% | Oct 2026 |
| Pictet - Robotics I dy EUR | 946K | 0.27% | +6.78% | Jul 2026 |
Top institutions holding ISRG.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 30.0M | 8.66% | -0.17% | Jun 2026 |
| Vanguard Capital Management, LLC | 23.1M | 6.67% | +0.22% | Jun 2026 |
| State Street Corp | 16.1M | 4.63% | +1.36% | Jun 2026 |
| Amvescap Plc. | 11.8M | 3.42% | +5.84% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 11.3M | 3.25% | -10.09% | Jun 2026 |
| Geode Capital Management, LLC | 8.53M | 2.46% | +0.80% | Jun 2026 |
| Capital World Investors | 7.74M | 2.23% | -3.79% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 7.24M | 2.09% | +0.13% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 6.56M | 1.89% | +8.29% | Jun 2026 |
| NORGES BANK | 4.95M | 1.43% | -1.78% | Jun 2026 |
| FMR Inc | 4.25M | 1.23% | -22.39% | Jun 2026 |
| JPMorgan Chase & Co | 4.23M | 1.22% | -7.90% | Jun 2026 |
| Fisher Asset Management, LLC | 3.92M | 1.13% | +1.71% | Jun 2026 |
| Wellington Management Company LLP | 3.80M | 1.10% | -3.97% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 3.74M | 1.08% | +77.84% | Jun 2026 |
| Jennison Associates LLC | 3.67M | 1.06% | +20.66% | Jun 2026 |
| AllianceBernstein L.P. | 3.63M | 1.05% | -4.72% | Jun 2026 |
| Northern Trust Corp | 3.51M | 1.01% | +0.25% | Jun 2026 |
| Bank of America Corp | 3.40M | 0.98% | -5.89% | Jun 2026 |
| Bank of New York Mellon Corp | 3.36M | 0.97% | -5.39% | Jun 2026 |
Intuitive Surgical Inc company profile
- Company name
- Intuitive Surgical Inc
- Ticker
- ISRG.US
- Exchange
- USA Stocks
- Listed since
- Jun 13, 2000
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 17,021
- Fiscal year end
- December
- Address
- 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304
- Phone
- 408 523 2100
- Website
- intuitive.com
About Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Intuitive Surgical Inc management
10- Dr. Gary S. Guthart Ph.D.Executive Chair · born 1966
- Mr. David J. RosaCEO & Director · born 1968
- Mr. Jamie E. SamathExecutive VP, CFO & Enterprise Technology Leader · born 1971
- Mr. Henry L. CharltonSenior VP of Global Business Operations · born 1970
- Mr. Gary H. Loeb J.D.Executive VP and Chief Legal & Compliance Officer · born 1970
- Mr. Mark P. BrosiusEVP, Chief Manufacturing & Supply Chain Officer · born 1967
- Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller
- Mr. Milind WagleChief Information Officer
- Mr. Daniel P. Connally C.F.A.VP & Head of Investor Relations
- Dr. Christopher R. Carlson Ph.D.Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures